LICENSE AGREEMENTLicense Agreement • August 19th, 2005 • Genetic Technologies LTD • Delaware
Effective as of February 5, 2004 ("EFFECTIVE DATE"), GENETIC TECHNOLOGIES LIMITED, having an office at 60 Hanover Street, Fitzroy, Victoria 3065, Australia ("GTG") and LABORATORY CORPORATION OF AMERICA HOLDINGS, a Delaware corporation having an office at 430 South Spring Street, Burlington, NC 27215, USA ("LICENSEE"), agree as follows:
LICENSE AGREEMENTLicense Agreement • August 19th, 2005 • Genetic Technologies LTD • New York
Effective as of September 17, 2004 ("EFFECTIVE DATE"), Genetic Technologies Limited, having an office at 60 Hanover Street, Fitzroy, Victoria 3065, Australia ("GTG") and Genzyme Corporation, having an office at 500 Kendall Street, Cambridge, MA, 02142, USA ("LICENSEE"), agree as follows:
License AgreementGenetic Technologies LTD • August 19th, 2005 • New York
Effective April 5th, 2002 ("EFFECTIVE DATE"), GeneType AG, a wholly owned subsidiary of Genetic Technologies Limited, having an office at 60-66 Hanover Street, Fitzroy, Victoria 3065, Australia ("LICENSOR") and Sequenom, Inc., having an office at 3595 John Hopkins Court, San Diego, California, USA and its Affiliates ("LICENSEE"), agree as follows:
License AgreementGenetic Technologies LTD • August 19th, 2005
Effective as of March 7, 2003 ("EFFECTIVE DATE"), GENETIC TECHNOLOGIES LIMITED, having an office at 60-66 Hanover Street, Fitzroy, Victoria 3065, Australia ("GTG") and PYROSEQUENCING AB, having an office at SE-752 28, Uppsala, Sweden ("LICENSEE"), agree as follows:
Clayton Utz Settlement and Licence Agreement Genetic Technologies Limited ACN 009 212 328 C Y O'Connor ERADE Village Foundation incorporating the Immunogenetics Research Foundation and the Institute of Molecular Genetics and Immunology Incorporated...Genetic Technologies LTD • August 19th, 2005 • Western Australia
the parties agreed to mutually release each other in relation to any claims each may have against the other for or in relation to any infringement of the IP owned by a party which occurred before the date of the Heads of Agreement.
LICENSE AGREEMENTLicense Agreement • August 19th, 2005 • Genetic Technologies LTD • New York
This License Agreement ("AGREEMENT"), effective this 31st day of December, 2003 ("EFFECTIVE DATE"), is by and between GENETIC TECHNOLOGIES LIMITED and its AFFILIATES, having an office at 60 Hanover Street, Fitzroy, Victoria 3065, Australia ("GTG") and TM BIOSCIENCE CORPORATION and its AFFILIATES, having an office at 439 University Avenue, Suite 1050, Toronto, Ontario, M5G 1Y8, Canada (collectively the "LICENSEE").
LICENSE AGREEMENTLicense Agreement • August 19th, 2005 • Genetic Technologies LTD • New York
Effective this day of September, 2004 ("EFFECTIVE DATE"), GENETIC TECHNOLOGIES LIMITED, having an office at 60 Hanover Street, Fitzroy, Victoria 3065, Australia ("LICENSEE") and METAMORPHIX, INC., a Delaware corporation, having an office at 8510A Corridor Road, Savage, Maryland 20763, and MMI GENOMICS, INC., a Delaware corporation, having an office at 1756 Picasso Avenue, Davis, California, 95616, USA (collectively, "LICENSOR"), agree as follows:
License AgreementLicense Agreement • August 19th, 2005 • Genetic Technologies LTD • Delaware
Effective as of August 1, 2003 ("EFFECTIVE DATE"), GENETIC TECHNOLOGIES LIMITED, having an office at 60 Hanover Street, Fitzroy, Victoria 3065, Australia ("GTG") and QUEST DIAGNOSTICS INCORPORATED, a Delaware corporation having an office at One Malcolm Avenue, Teterboro, NJ 07608, USA ("LICENSEE"), agree as follows:
License AgreementGenetic Technologies LTD • August 19th, 2005 • Delaware
Effective April 12, 2002, 2002 ("EFFECTIVE DATE"), GeneType AG, a wholly owned subsidiary of Genetic Technologies Limited, having an office at 60-66 Hanover Street, Fitzroy, Victoria 3065, Australia ("LICENSOR") and Nanogen, Inc., having an office at 10398 Pacific Center Court, San Diego, CA 92121, USA ("LICENSEE"), agree as follows:
Myriad/Genetic Technologies Marketing and Patent License AgreementGenetic Technologies LTD • August 19th, 2005
This Myriad/Genetic Technologies Patent License Agreement ("Agreement") is entered into as of October , 2002 ("Effective Date") by and between the Parties,
Non-Commercial Research LicenseGenetic Technologies LTD • August 19th, 2005 • New South Wales
Effective July 22, 2003 ("EFFECTIVE DATE"), GENETIC TECHNOLOGIES LIMITED, having an office at 60 Hanover Street, Fitzroy, Victoria 3065, Australia ("GTG") and THE UNIVERSITY OF SYDNEY, being a body corporate established pursuant to the University of Sydney Act (1989) of The University of Sydney, New South Wales 2006, Australia ("LICENSEE"), agree as follows:
LICENSE AGREEMENTLicense Agreement • August 19th, 2005 • Genetic Technologies LTD • California
Effective this day of September, 2004 ("EFFECTIVE DATE"), GENETIC TECHNOLOGIES LIMITED, having an office at 60 Hanover Street, Fitzroy, Victoria 3065, Australia ("GTG") and METAMORPHIX, INC., a Delaware corporation, having an office at 8510A Corridor Road, Savage, Maryland 20763 ("LICENSEE"), agree as follows:
CONSULTANCY AGREEMENTAgreement • August 19th, 2005 • Genetic Technologies LTD • Victoria
The Company wishes to engage the Consultant to provide the Consultancy Services on the terms and conditions contained in this agreement.
License AgreementSubscription Agreement • August 19th, 2005 • Genetic Technologies LTD • New York
Effective August 20, 2002 ("EFFECTIVE DATE"), GeneType AG, a wholly owned subsidiary of Genetic Technologies Limited, having an office at 60-66 Hanover Street, Fitzroy, Victoria 3065, Australia ("LICENSOR") and Perlegen Sciences, Inc., having an office at 2021 Stierlin Court, Mountain View, California, 94043 ("LICENSEE"), agree as follows:
CLAYTON UTZ Sponsored Research Agreement Genetic Technologies Limited ACN 009 212 328 C Y O'Connor ERADE Village Foundation incorporating the Immunogenetics Research Foundation and the Institute of Molecular Genetics and Immunology Incorporated (ABN...Genetic Technologies LTD • August 19th, 2005 • Western Australia
